A Central Index Key (CIK) is a unique identifier assigned by the SEC to each filer.

Why are some filings missing?

New filings appear as the SEC updates EDGAR, and older records can vary by availability.

How often is this page updated?

Updates follow new EDGAR submissions and periodic data refreshes.

SEC EDGAR filings, ownership reports, and insider transactions for John Sang Lee.

Business address: C/O Phasebio Pharmaceuticals, Inc., 1 Great Valley Pkwy., Suite 30, Malvern, PA, 19355

Get insider transactions for this reporting owner

John Sang Lee has filed 5 SEC EDGAR filings since 17 Oct 2018

Recent SEC filings for John Sang Lee including 4, 3.

Form type	Document	Filing	Description	Filing date	Reporting date	File number(s)
4	Open 4 document	View SEC filing for 4	FORM 4	28 Feb 2022	24 Feb 2022	001-38697
4	Open 4 document	View SEC filing for 4	FORM 4	09 Feb 2021	05 Feb 2021	001-38697
4	Open 4 document	View SEC filing for 4	FORM 4	14 Feb 2020	12 Feb 2020	001-38697
4	Open 4 document	View SEC filing for 4	FORM 4 SUBMISSION	01 Mar 2019	01 Mar 2019	001-38697
3	Open 3 document	View SEC filing for 3	FORM 3 SUBMISSION	17 Oct 2018	17 Oct 2018	001-38697

John Sang Lee files with the SEC under CIK 0001755665. This page aggregates EDGAR filings and related ownership activity.

What is a CIK?: A Central Index Key (CIK) is a unique identifier assigned by the SEC to each filer.
Why are some filings missing?: New filings appear as the SEC updates EDGAR, and older records can vary by availability.
How often is this page updated?: Updates follow new EDGAR submissions and periodic data refreshes.